Thursday, January 21, 2021 12:37:40 PM
Recent ADTX News
- Aditxt’s Subsidiary Pearsanta to Collaborate with Evofem Biosciences for Targeted U.S. Launch of Endometriosis Diagnostic in Mid-2025 • Business Wire • 09/20/2024 12:15:00 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 09/16/2024 08:20:07 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 09/16/2024 04:15:14 AM
- Form S-3/A - Registration statement under Securities Act of 1933: [Amend] • Edgar (US Regulatory) • 09/11/2024 09:20:03 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/09/2024 08:15:39 PM
- Aditxt and Evofem Sign Second Amendment to Amended and Restated Merger Agreement, Target Closing of Acquisition in Fourth Quarter of 2024 • Business Wire • 09/09/2024 12:15:00 PM
- Form S-3 - Registration statement under Securities Act of 1933 • Edgar (US Regulatory) • 09/06/2024 09:04:00 PM
- Form 425 - Prospectuses and communications, business combinations • Edgar (US Regulatory) • 09/06/2024 08:16:29 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/06/2024 08:15:09 PM
- Form 8-K/A - Current report: [Amend] • Edgar (US Regulatory) • 09/05/2024 01:22:30 PM
- Form 8-K/A - Current report: [Amend] • Edgar (US Regulatory) • 09/05/2024 01:18:07 PM
- Aditxt Subsidiary Pearsanta Submits a Grant Application Seeking to Advance Clinical Trials for Mitomic® Prostate Test, Targeting Early Detection in High-Risk Patients • Business Wire • 09/04/2024 12:15:00 PM
- Aditxt to Present at the H.C. Wainwright 26th Annual Global Investment Conference September 9th-11th, 2024 • Business Wire • 08/29/2024 12:15:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/28/2024 08:30:21 PM
- Aditxt’s Precision Health Subsidiary, Pearsanta, Appoints Christopher Mitton as President as it Seeks to Complete Clinical Validation Studies for its Mitomic® Endometriosis Test (MET™) and Mitomic® Prostate Test (MPT™) • Business Wire • 08/26/2024 12:15:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/21/2024 08:44:14 PM
- Aditxt Announces Third Amendment to Arrangement Agreement with Appili Therapeutics • Business Wire • 08/21/2024 12:15:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/19/2024 08:16:12 PM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 08/14/2024 08:15:25 PM
- Evofem Biosciences Announces Financial Results for the Second Quarter of 2024 • PR Newswire (US) • 08/14/2024 11:00:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/13/2024 08:15:09 PM
- Aditxt Announces the Successful Passage of all Proposals at Recent Annual Shareholders’ Meeting, Setting the Stage for 2024 and 2025 Strategic Plans • Business Wire • 08/13/2024 12:15:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/09/2024 08:15:21 PM
- Aditxt Announces Closing of $1.2 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules • Business Wire • 08/09/2024 08:15:00 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 08/09/2024 02:28:09 PM
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM
Dear Cashmere Group Holding Co. AKA Swifty Global Signs Binding Letter of Intent to be Acquired by Signing Day Sports • DRCR • Sep 19, 2024 10:26 AM
HealthLynked Launches Virtual Urgent Care Through Partnership with Lyric Health. • HLYK • Sep 19, 2024 8:00 AM
Element79 Gold Corp. Appoints Kevin Arias as Advisor to the Board of Directors, Strengthening Strategic Leadership • ELMGF • Sep 18, 2024 10:29 AM
Mawson Finland Limited Further Expands the Known Mineralized Zones at Rajapalot: Palokas step-out drills 7 metres @ 9.1 g/t gold & 706 ppm cobalt • MFL • Sep 17, 2024 9:02 AM
PickleJar Announces Integration With OptCulture to Deliver Holistic Fan Experiences at Venue Point of Sale • PKLE • Sep 17, 2024 8:00 AM